Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Study Evaluating 89ZrPanitumumab for Assessment of Indeterminate Metastatic and/or Primary Lesion(s) on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma

Head/Neck

Disease Sites: Head/Neck

Phase: I

Investigator: Topf, Michael

NCTID: NCT05747625

Protocol No: VICCHN2279

Phase I/II Trial of Gabapentin plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation.

Multiple Cancer Types

Disease Sites: Head/Neck, Phase I

Phase: I/II

Investigator: Lockney, Natalie

NCTID: NCT05156060

Protocol No: VICCHNP2173

Neoadjuvant REGN2810 (Cemiplimab) in Cutaneous Basal Cell Carcinoma of the Head and Neck

Head/Neck

Disease Sites: Head/Neck

Phase: II

Investigator: Topf, Michael

NCTID: NCT05929664

Protocol No: VICC-ITHAN23127

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects With Select Solid Tumors

Multiple Cancer Types

Disease Sites: Breast, Cervical, Gastrointestinal, Gynecologic, Head/Neck, Lung, Phase I, Urologic

Phase: I

Investigator: Berlin, Jordan

NCTID: NCT05683418

Protocol No: VICC-DTPHI23103

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form